Skip to main content

Johns Hopkins International Conference on Drug Affordability and Pricing

Public-Facing Webinars and Symposiums
Wednesday, February 5, 2025, 9:00 a.m. - 12:00 p.m. ET
Location
Zoom
Online
Past Event

The Drug Access & Affordability Initiative and Institute for Health and Social Policy invites you to the International Conference on Drug Pricing and Affordability. This virtual conference will bring together global experts to address critical challenges in drug pricing and affordability, fostering impactful discussions and actionable insights.

Conference Details: 

Date: Wednesday, February 5th, 2025

Time: 9:00 AM – 12:00 PM EST

Venue: Virtual (Zoom)

Register in advance for this webinar:
https://jh.zoom.us/webinar/register/WN_lrMyu2rrQnebS8mns11ZRQ

 

Panel 1: Drug Shortages and Global Supply Chain

Moderator: Mariana Socal, Johns Hopkins University

Panelists:

•              Diego Ocampo, Director of Innovation at Neolpharma

•              Prashnat Yadav, Council of Foreign Relations

•              Katherine E. Bliss, Center for Strategic, and International Studies

This session will explore the pros and cons of a globalized supply chain, its implications for public health and security, and success stories in building resilience.

 

Panel 2: Out-of-Pocket Spending on Medications

Moderator: Antonio Trujillo, Johns Hopkins University

Panelists:

•              Senator Dylan Roberts, Colorado Eight Senate District

•              David Morgan, OECD Directorate for Employment, Labour, and Social Affairs

•              Prof. Reinhard Busse, Academic Tu-Berlin 

This session will include a comparative discussion of international strategies to reduce patient cost burdens, featuring insights from Germany, the U.S., and other OECD countries.

 

Panel 3: Health Technology Assessment

Moderator: Jeromie Ballreich, Johns Hopkins University

Panelists:

•              Wija Oortwijn, Radboud University Netherlands

•              Daniel Ollendorf, Chief Clinical Officer, Institute for Clinical and Economic Review

•              Micheal DiStefano, University of Colorado

 This session will examine how HTA shapes drug pricing and coverage decisions, with a focus on innovations like cell and gene therapies, AI, and EU Joint Clinical Assessments.

 Closing remark by Vicente Navarro, Professor, Johns Hopkins University

 



 

Contact Info

Joy Acha